Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Campath
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Reuters
Campath
Lemtrada
leukemia
Sanofi
News
Genzyme to push argument for Campath value
Yahoo/Reuters
Campath
Genzyme
M&A
Sanofi
News
Termeer Touts Campath-Linked CVRs
InVivo
Campath
Genzyme
Henri Termeer
MS
multiple sclerosis
Sanofi
News
Genzyme Considers a Way Around Campath Impasse
WSJ Online
Campath
Genzyme
MS
multiple sclerosis
News
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Campath
Genzyme
M&A
MS
multiple sclerosis
Sanofi
»
1 comment
News
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Campath
Genzyme
MS
multiple sclerosis
»
2 comments
News
Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Campath
Genzyme
M&A
MS
multiple sclerosis
Sanofi
teriflunomide
»
Login
or
register
to post comments
News
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Campath
cancer
Genzyme
MS
multiple sclerosis
»
Login
or
register
to post comments
News
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Campath
Carl Icahn
Genzyme
MS
multiple sclerosis
»
Login
or
register
to post comments
News
Genzyme sees MS drug topping efficacy league
Reuters
Campath
Genzyme
MS
multiple sclerosis
»
8 comments
1
2
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT